Environmental Factors and Their Regulation of Immunity in Multiple Sclerosis

Abstract In multiple sclerosis (MS), environmental factors and genetic traits cooperate in the induction of the chronic activation of immune cells to produce the brain pathology. Epidemiology has focused on different environmental risk factors but certainly virus infection, smoking, vitamin D levels, and sunlight exposure are the most relevant. What is certainly less clear is the way in which these external factors are able to induce and sustain the internal pathology process of the disease. Epigenetics has been recently focused on trying to shed light on this aspect. As a matter of fact epigenetic changes are highly sensitive to environmental factors that therefore may influence the susceptibility to the disease by acting through epigenetic modifications. In this chapter we discuss the most relevant environmental factors and how they may affect the immune response in MS. Finally, we discuss the possible role of the microbiota in inducing autoimmunity in MS.

[1]  R. Liblau,et al.  Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis , 2011, FEBS letters.

[2]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[3]  L. Blizzard,et al.  Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[5]  D. Halbert,et al.  T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. , 2002, Cellular immunology.

[6]  Pierre Grammond,et al.  Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis , 2012, PloS one.

[7]  A. Mildner,et al.  Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes , 2007, Nature Genetics.

[8]  Tsung-Cheng Chang,et al.  microRNAs in vertebrate physiology and human disease. , 2007, Annual review of genomics and human genetics (Print).

[9]  M. Ramanathan,et al.  Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis , 2009, Neurology.

[10]  N. Rajewsky,et al.  Regulation of the Germinal Center Response by MicroRNA-155 , 2007, Science.

[11]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Krumbholz,et al.  Humoral autoimmunity in multiple sclerosis , 2011, Journal of the Neurological Sciences.

[13]  P. Rieckmann,et al.  The natural history of primary progressive multiple sclerosis , 2009, Neurology.

[14]  A. Kessels,et al.  Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis , 2008, Multiple sclerosis.

[15]  Eman N. Ali,et al.  Smoking and disease progression in multiple sclerosis. , 2009, Archives of neurology.

[16]  E. Coccia,et al.  Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation , 2010, Journal of neuropathology and experimental neurology.

[17]  J. Pers,et al.  Epigenetics and autoimmunity. , 2010, Journal of autoimmunity.

[18]  J. Mendell,et al.  MicroRNAs in cell proliferation, cell death, and tumorigenesis , 2006, British Journal of Cancer.

[19]  Lorraine Lau,et al.  MMPs in the central nervous system: where the good guys go bad. , 2008, Seminars in cell & developmental biology.

[20]  Arne Svejgaard,et al.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.

[21]  D. Foureau,et al.  Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.

[22]  E. Granieri,et al.  Incidence of multiple sclerosis in Macomer, Sardinia, 1912–1981 , 1986, Neurology.

[23]  A. Ascherio,et al.  Vitamin D and multiple sclerosis , 2010, The Lancet Neurology.

[24]  A. Noor,et al.  Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated , 2007, Journal of neuroscience research.

[25]  F. Barkhof,et al.  Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial , 2011, The Lancet.

[26]  A. Sadovnick,et al.  Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[27]  F. Mastronardi,et al.  The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis , 2006, Neurochemical Research.

[28]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[29]  Mathew B. Cox,et al.  MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood , 2010, PloS one.

[30]  G. Pantaleo,et al.  HLA-B7–Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis , 2012, The Journal of Immunology.

[31]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[32]  M. Hernán,et al.  Cigarette smoking and the progression of multiple sclerosis. , 2005, Brain : a journal of neurology.

[33]  I. Adcock,et al.  Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  G. Teng,et al.  Shhh! Silencing by microRNA-155 , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[35]  L. Wilkins A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis , 2010, Neurology.

[36]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[37]  T. Bestor,et al.  Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.

[38]  V. Yong,et al.  Environmental factors and their regulation of immunity in multiple sclerosis , 2012, Journal of the Neurological Sciences.

[39]  T. Gant,et al.  Smoking induces differential miRNA expression in human spermatozoa: A potential transgenerational epigenetic concern? , 2012, Epigenetics.

[40]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[41]  T. Olsson,et al.  Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.

[42]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[43]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[44]  M. Pender CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis , 2012, Autoimmune diseases.

[45]  M. Campbell,et al.  KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. , 2011, Human molecular genetics.

[46]  Emily Bernstein,et al.  RNA meets chromatin. , 2005, Genes & development.

[47]  J. Antel,et al.  Myelin basic protein and human coronavirus 229E cross‐reactive T cells in multiple sclerosis , 1996, Annals of neurology.

[48]  Ryan M. O’Connell,et al.  MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. , 2010, Immunity.

[49]  C. Ackerley,et al.  Myelin in multiple sclerosis is developmentally immature. , 1994, The Journal of clinical investigation.

[50]  J. Lünemann,et al.  Viral triggers of multiple sclerosis , 2010, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

[51]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[52]  K. Berer,et al.  Remote control-triggering of brain autoimmune disease in the gut. , 2013, Current opinion in immunology.

[53]  A. M. Walker,et al.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology. , 1980, Journal of epidemiology and community health.

[54]  B. Becher,et al.  T(H)17 cytokines in autoimmune neuro-inflammation. , 2011, Current opinion in immunology.

[55]  Thomas Tuschl,et al.  MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. , 2008, Immunity.

[56]  J. Minárovits,et al.  Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. , 2009, Seminars in cancer biology.

[57]  L. Nagy,et al.  1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype12 , 2009, The Journal of Immunology.

[58]  A. Bergamini,et al.  1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. , 2009, Cytokine.

[59]  R. Coletta,et al.  Impact of smoking on inflammation: overview of molecular mechanisms , 2011, Inflammation Research.

[60]  J. Correale,et al.  Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.

[61]  T. Kuhlmann,et al.  Changed Histone Acetylation Patterns in Normal-Appearing White Matter and Early Multiple Sclerosis Lesions , 2011, The Journal of Neuroscience.

[62]  Wei Cheng,et al.  Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS. , 2012, Frontiers in bioscience.

[63]  Antonio J. Berlanga-Taylor,et al.  Rare variants in the CYP27B1 gene are associated with multiple sclerosis , 2011, Annals of neurology.

[64]  P. Hart,et al.  Modulation of the immune system by UV radiation: more than just the effects of vitamin D? , 2011, Nature Reviews Immunology.

[65]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[66]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[67]  V. Yong,et al.  Predominance of Th2 polarization by Vitamin D through a STAT6-dependent mechanism , 2011, Journal of Neuroinflammation.

[68]  H. Lassmann,et al.  MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. , 2009, Brain : a journal of neurology.

[69]  M. Hernán,et al.  Cigarette smoking and incidence of multiple sclerosis. , 2001, American journal of epidemiology.

[70]  C. Martyn,et al.  Migrant studies in multiple sclerosis , 1995, Progress in Neurobiology.

[71]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[72]  D. Clayton,et al.  Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. , 1996, Brain : a journal of neurology.

[73]  Weiliang Qiu,et al.  Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. , 2012, Human molecular genetics.

[74]  A. Lutterotti,et al.  Smoking is a risk factor for early conversion to clinically definite multiple sclerosis , 2008, Multiple sclerosis.

[75]  M. Alter,et al.  Risk of multiple sclerosis related to age at immigration to Israel. , 1966, Archives of neurology.

[76]  N. Cerf-Bensussan,et al.  The immune system and the gut microbiota: friends or foes? , 2010, Nature Reviews Immunology.

[77]  L. Martin,et al.  Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation , 2011, The Journal of Neuroscience.

[78]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[79]  Mary T. Brinkoetter,et al.  A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis , 2011, Nature Medicine.

[80]  Jiuhong Kang,et al.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.

[81]  P. Joensen Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands , 2011, Multiple sclerosis.

[82]  O. Griesbeck,et al.  In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. , 2010, Immunity.

[83]  T. Yamamura,et al.  Immunopathology and Infectious Diseases NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora , 2010 .

[84]  Sneha S. Joshi,et al.  1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A , 2011, Molecular and Cellular Biology.

[85]  A. Ivanov,et al.  Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross‐react with myelin basic protein and EBV antigen , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  Luanne M. Metz,et al.  Epigenetic changes in patients with multiple sclerosis , 2013, Nature Reviews Neurology.

[87]  K. Berer,et al.  Microbial view of central nervous system autoimmunity , 2014, FEBS letters.

[88]  J M Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[89]  S. Patten,et al.  A Quantitative Analysis of Suspected Environmental Causes of MS , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[90]  H. Weiner,et al.  Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Immunology.

[91]  F. Roman,et al.  Developmental vitamin D deficiency alters learning in C57Bl/6J mice , 2010, Behavioural Brain Research.

[92]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[93]  M. Fabbri,et al.  Regulatory mechanisms of microRNAs involvement in cancer , 2007, Expert opinion on biological therapy.

[94]  D. Bourdette,et al.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis , 2008, Current neurology and neuroscience reports.

[95]  K. Berer,et al.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.

[96]  S. Miller,et al.  Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease , 2011, Immunological reviews.

[97]  T. Köse,et al.  Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. , 2011, Oral diseases.

[98]  J. Knight,et al.  Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.

[99]  Michael Weber,et al.  Genomic patterns of DNA methylation: targets and function of an epigenetic mark. , 2007, Current Opinion in Cell Biology.

[100]  R. Knight,et al.  The Human Microbiome Project , 2007, Nature.

[101]  T. Holmøy,et al.  Vitamin D in the healthy and inflamed central nervous system: access and function , 2011, Journal of the Neurological Sciences.

[102]  T. Dwyer,et al.  Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.

[103]  S. Muller,et al.  Epigenetic Histone Code and Autoimmunity , 2010, Clinical reviews in allergy & immunology.

[104]  K. Berer,et al.  Commensal gut flora and brain autoimmunity: a love or hate affair? , 2012, Acta Neuropathologica.

[105]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[106]  Philip W. Landfield,et al.  Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[107]  T. Dwyer,et al.  Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis , 2009, Journal of Neurology.

[108]  George A. Calin,et al.  Mammalian microRNAs: a small world for fine-tuning gene expression , 2006, Mammalian Genome.

[109]  M. Campbell,et al.  Vitamin D has wide regulatory effects on histone demethylase genes , 2012, Cell cycle.

[110]  S. Mazmanian,et al.  Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.

[111]  Michael K. Skinner,et al.  Epigenetic transgenerational actions of environmental factors in disease etiology , 2010, Trends in Endocrinology & Metabolism.

[112]  A. Bar-Or,et al.  B cells in multiple sclerosis: connecting the dots. , 2011, Current opinion in immunology.